General News Regulated Oxurion Avoids Bankruptcy, Announces Board and Management Changes and Enters into Binding Letter of Intent with its Main Creditor Atlas EN NL December 28, 2023
News Regulated Transparency/Denominator Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC EN NL December 1, 2023
News Regulated Oxurion Discloses Topline Data from KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema EN NL November 20, 2023
News Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas EN NL November 19, 2023
General News Oxurion Receives EUR 1.0 Million under Amended Atlas Funding Program Total of EUR 3.5 Million in Unconditional Funding Allowing Company to Reach Topline Data from KALAHARI Trial This Year EN November 16, 2023
News Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas EN NL November 16, 2023
News Regulated Transparency/Denominator Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC EN NL November 15, 2023
News Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas EN NL November 6, 2023
News Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas EN NL November 3, 2023
News Regulated Transparency/Denominator Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC EN NL October 30, 2023
General News Oxurion Receives EUR 1.5 Million under Amended Atlas Funding Program; Total of EUR 3.5 Million in Unconditional Funding Allowing Company to Achieve Topline Data from KALAHARI Trial EN October 25, 2023
News Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas EN NL October 20, 2023
News Regulated Transparency/Denominator Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC EN NL October 20, 2023
News Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas EN NL October 10, 2023
News Regulated Transparency/Denominator Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC EN NL October 3, 2023
News Regulated Transparency/Denominator Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC EN NL September 27, 2023
News Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas EN NL September 18, 2023
News Regulated Transparency/Denominator Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC EN NL September 18, 2023
General News Oxurion Receives First EUR 1 Million under Amended Atlas Funding Program EN September 18, 2023
